Back to search

Peptide record

TPDB12662

Antibacterial Hemolysis Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12662
Antibacterial Hemolysis Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Hemolysis, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
LLKLLKWLLKLLK
Physicochemical Analysis
C83H148N18O14
ARNDCEQGHIMFPSTYV
L
1622.20
11.00
4
0
9
+4
-2.37
1.069
240.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
5500
339.05
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
8
L
4
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 8 K: 4 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
13
C83H148N18O14
1622.20
11.00
+4
-2.37
1.069
Evidence Records 14 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

B. subtilis ATCC 6633

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S.epidermis ATCC 12228 (MIC 50 ug/ml), M. luteus AT
Evidence 2 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

Staphylococcus aureus ATCC 6538p

Source & Reference

dbAMP DRAMP

Other

active against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S.epidermis ATCC 12228 (MIC 50 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E.col
Evidence 3 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

S.epidermis ATCC 12228

Source & Reference

dbAMP DRAMP

Other

against Gram+ B. subtilis ATCC 6633 (MIC 6.3 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S.epidermis ATCC 12228 (MIC 50 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S.dysent
Evidence 4 Activity

Activity

MIC
Antibacterial
6.3 µg/mL

Target

M. luteus ATCC 10240

Source & Reference

dbAMP DRAMP

Other

C 6.3 ug/ml), S. aureus ATCC 6538p (MIC 25 ug/ml), S.epidermis ATCC 12228 (MIC 50 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S.dysentariae ATCC 9752 (MIC >200 ug/ml), S.ty
Evidence 5 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

E.coli ATCC 25922

Source & Reference

dbAMP DRAMP

Other

g/ml), S.epidermis ATCC 12228 (MIC 50 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S.dysentariae ATCC 9752 (MIC >200 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.p
Evidence 6 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

S.dysentariae ATCC 9752

Source & Reference

dbAMP DRAMP

Other

0 ug/ml), M. luteus ATCC 10240 (MIC 6.3 ug/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S.dysentariae ATCC 9752 (MIC >200 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and
Evidence 7 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

S.typhimorium ATCC 14028

Source & Reference

dbAMP DRAMP

Other

/ml), Gram- E.coli ATCC 25922 (MIC >200 ug/ml), S.dysentariae ATCC 9752 (MIC >200 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and P.aeruginosa ATCC 27853 (MIC >200 ug/ml).
Evidence 8 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

K.pneumoniae ATCC 10031

Source & Reference

dbAMP DRAMP

Other

ml), S.dysentariae ATCC 9752 (MIC >200 ug/ml), S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and P.aeruginosa ATCC 27853 (MIC >200 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
>200 µg/mL

Target

P.aeruginosa ATCC 27853

Source & Reference

dbAMP DRAMP

Other

S.typhimorium ATCC 14028 (MIC >200 ug/ml), K.pneumoniae ATCC 10031 (MIC >200 ug/ml), and P.aeruginosa ATCC 27853 (MIC >200 ug/ml).
Evidence 10 Activity

Activity

36% Hemolysis
Toxicity
200 µg/mL
Hemolytic Cytotoxic
36% Hemolysis | 200 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009
Evidence 11 Activity

Activity

8% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
8% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009
Evidence 12 Activity

Activity

5% Hemolysis
Toxicity
12.5 µg/mL
Hemolytic Cytotoxic
5% Hemolysis | 12.5 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009
Evidence 13 Activity

Activity

4% Hemolysis
Toxicity
6.3 µg/mL
Hemolytic Cytotoxic
4% Hemolysis | 6.3 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
De novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. | J Pept Sci | 2009
Evidence 14 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis